How to Navigate Ecosystem Connect NEWDistinguished Investigators Global Conferences RLT Education RLT Components Sponsors Trial Stats
Utility of 18F-rhPSMA-7.3 in the Diagnosis of Prostate Cancer After Focal Gland Treatment
Description:
To evaluate the effectiveness of a PSMA-PET scan in identifying recurrent prostate cancer after focal therapy
Sponsor:
Hackensack Meridian Health
Contacts:
Oncology Clinical Research Referral Officeoncologyresearchreferral@hmhn.org
551-996-1777
Government Study Link:
NCT07011342 - Click here to see study onClinicalTrials.gov
18F-rhPSMA-7.3
Isotope(s):
Target(s):
- PSMA
